For instance, Liu et al., revealed that AURKB is related to paclitaxel resistance in BC cells through the PRKCE/RAB27B axis, suggesting a possible intervention target to reverse tumor drug resistance [46]. This evidence concerns the gene AURKB and breast cancer.